Recommendations for the registration of agents used in the prevention and treatment of glucocorticoid-induced osteoporosis.

Calcified tissue international

Volumn 59, Issue 5, 1996, Pages 323-327

  Compston, J E ^a   Audran, M ^b   Avouac, B ^c   Bouvenot, G ^d   Devogelaer, J P ^e   Eastell, R ^f   Fabris, F ^g   Gennari, C ^h   Jones, E A ⁱ   Kaufman, J M ^j   Lemmel, E M ^k   Mazzuoli, G ^l   Reid, D M ^m   Ringe, J D ⁿ   Vanhaelst, L ^o   Ziegler, R ^p   Reginster, J Y ^q  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ANGERS UNIVERSITY HOSPITAL   (France)

^c HENRI MONDOR HOSPITAL   (France)

^d HÔPITAL SAINTE MARGUERITE   (France)

^e CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^f UNIVERSITY OF SHEFFIELD   (United Kingdom)

^g UNIVERSITY OF TURIN   (Italy)

^h Policlinico Universitario   (Italy)

ⁱ ACADEMIC MEDICAL CENTER   (Netherlands)

^j GHENT UNIVERSITY HOSPITAL   (Belgium)

^k Staatl Rheumakrankenhaus   (Germany)

^l POLICLINICO UMBERTO I   (Italy)

^m UNIVERSITY OF ABERDEEN   (United Kingdom)

ⁿ UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^o VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^p UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^q UNIVERSITY OF LIÈGE   (Belgium)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID;

ANIMAL; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; DRUG APPROVAL; DRUG THERAPY; EDITORIAL; HUMAN; OSTEOPOROSIS; STANDARD;

ANIMALS; CLINICAL TRIALS; DRUG APPROVAL; DRUG THERAPY; GLUCOCORTICOIDS; HUMANS; OSTEOPOROSIS;

EID: 0030294231     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002239900134     Document Type: Editorial

References (0)